StockData
Ligand Pharmaceuticals Inc logo

Ligand Pharmaceuticals Inc (LGND) shareholders

LGNDNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as LGNDZ, LGNXZ, LGNYZ, LGNZZ
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 6/30433% above fair value
$293.81−7.90 (-2.62%)

Close on Nov 17, 2026Market cap $5.88BP/E 128.3Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
23M
Shares held, 13F filers
Institutional holders
415
97 new, 34 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 151 sales
Net sold $36.52M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.2,839,25114.50%13G (passive) amendmentSep 30, 2025
Invesco Ltd.1,520,9117.60%13G (passive) amendmentSep 30, 2026
Vanguard Portfolio Management1,109,1545.56%13G (passive)Mar 31, 2026
Janus Henderson Group PLC1,042,3785.30%13G (passive) amendmentSep 30, 2025
Vanguard Capital Management997,6375.00%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of LGNDValueChange% of portfolio
BlackRock, Inc.3,100,996–$980.19M+139,0730.01%
Invesco Ltd.1,201,644–$379.83M+378,0400.03%
Vanguard Portfolio Management LLC1,138,316–$359.81M+38,0490.02%
Jupiter Topco LLC1,040,578–$328.91MNew0.13%
Vanguard Capital Management LLC870,950–$275.30M+22,8610.01%
State Street Corp826,539–$261.25M+47,6830.01%
FMR LLC762,827–$241.12M+166,7000.01%
Franklin Resources Inc752,044–$237.71M+178,8670.05%
Congress Asset Management Co /Ma659,911–$208.59M+155,2741.28%
Geode Capital Management, LLC589,020–$186.21M+30,0860.01%
Nomura Asset Management International Inc.568,371–$179.66M−4,9410.27%
Chicago Capital, LLC553,435–$174.94M−8,2404.21%
Stephens Investment Management Group LLC475,609–$150.34M−19,0611.61%
Dimensional Fund Advisors LP429,314–$135.70M+4,0840.02%
Massachusetts Financial Services Co /Ma/375,762–$118.77M−35,7810.04%
Goldman Sachs Group Inc323,245–$102.17M−57,8660.01%
Loomis Sayles & Co L P291,805–$92.24M−61,4040.12%
Rice Hall James & Associates, LLC270,052–$85.36M−13,5154.15%
Ranger Investment Management, L.P.257,596–$81.42M−10,3475.15%
Northern Trust Corp257,389–$81.36M+3,2310.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 202641523M97 / 149114 / 344M1M
Q1 202635921M59 / 133115 / 433M1M
Q4 202535021M70 / 110116 / 302M2M
Q3 202531421M64 / 100103 / 163M1M
Q2 202527119M33 / 11088 / 231M1M
Q1 202526219M33 / 10286 / 271M1M
Q4 202425818M41 / 10862 / 221M1M
Q3 202424318M38 / 9753 / 284M1M
Q2 202423517M43 / 8273 / 272M2M
Q1 202422217M33 / 6471 / 192M1M
Q4 202321116M34 / 7271 / 171M1M
Q3 202319616M20 / 6777 / 271M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

391 funds held LGND in Q2 2026, 41% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of LGNDValue% of fundAs of
iShares Core S&P Small-Cap ETF1,207,351–$381.63M0.34%Jun 30, 2026
Vanguard Total Stock Market Index Fund605,720–$191.46M0.01%Jun 30, 2026
Franklin Dynatech Fund550,000–$173.85M0.58%Jun 30, 2026
Invesco Discovery Fund519,159–$120.42M1.54%May 31, 2026
iShares Russell 2000 ETF515,565–$162.96M0.20%Jun 30, 2026
Janus Henderson Triton Fund494,252–$156.23M2.63%Jun 30, 2026
Vanguard Small-Cap Index Fund436,817–$138.07M0.07%Jun 30, 2026
Nomura Small Cap Core Fund385,274–$89.37M1.62%May 29, 2026
Fidelity Small Cap Value Fund325,665–$93.64M1.71%Jul 31, 2026
Vanguard Small-Cap Value Index Fund276,594–$87.43M0.13%Jun 30, 2026
Janus Henderson Venture Fund275,579–$87.11M2.41%Jun 30, 2026
Congress Small Cap Growth Fund271,577–$78.09M3.89%Jul 31, 2026
Vanguard Explorer Fund234,250–$67.36M0.30%Jul 31, 2026
Vanguard Extended Market Index Fund229,869–$72.66M0.07%Jun 30, 2026
Fidelity Small Cap Index Fund219,513–$63.12M0.19%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Todd C. DavisChief Executive Officer, Director199,513Jul 6, 2026
Andrew ReardonCLO & Secretary31,854Nov 4, 2026
Octavio EspinozaChief Financial Officer48,818Aug 14, 2026
Martine ZimmermannDirector1,782Nov 16, 2026
John W. KozarichDirector42,122Nov 16, 2026
Jason AryehDirector113,476Nov 12, 2026
Jason HaasDirector3,981Aug 14, 2026
Stephen L. SabbaDirector33,629Jun 18, 2026
John L. LamattinaDirector31,071Jun 12, 2026
Nancy Ryan GrayDirector8,930Jun 9, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Martine Zimmermann
Director
Nov 12, 2026Sale−2,000$318.17$636.34K1,782
John W. Kozarich
Director
Nov 12, 2026Sale(10b5-1 plan)−500$325.00$162.50K42,122
Jason Aryeh
Director
Nov 10, 2026Sale−500$320.20$160.10K105,476
Jason Aryeh
Director
Nov 10, 2026Sale−500$320.10$160.05K105,976
Jason Aryeh
Director
Nov 10, 2026Sale−10$320.02$3.20K106,476
Jason Aryeh
Director
Nov 10, 2026Sale−646$320.00$206.72K106,486
Jason Aryeh
Director
Nov 10, 2026Sale−844$320.00$270.08K107,132
Jason Aryeh
Director
Nov 10, 2026Sale−500$319.99$160.00K107,976
Jason Aryeh
Director
Nov 4, 2026Sale−282$319.99$90.24K108,476
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−120$323.14$38.78K31,854
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−200$321.44$64.29K31,974
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−320$319.97$102.39K32,174
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−440$318.73$140.24K32,494
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−280$317.91$89.01K32,934
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−80$314.58$25.17K33,214
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−403$313.75$126.44K33,294
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−634$312.85$198.35K33,697
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−520$311.72$162.09K34,331
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−490$310.61$152.20K34,851
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−522$309.91$161.77K35,341
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−708$308.43$218.37K35,863
Andrew Reardon
CLO & Secretary
Nov 2, 2026Sale(10b5-1 plan)−283$307.39$86.99K36,571
Andrew Reardon
CLO & Secretary
Nov 2, 2026Option exercise+5,000$52.27$261.35K36,854
Jason Aryeh
Director
Nov 2, 2026Sale−700$320.43$224.30K108,758
Jason Aryeh
Director
Oct 30, 2026Sale−50$320.49$16.02K109,458
Jason Aryeh
Director
Oct 30, 2026Sale−1,209$320.42$387.38K109,508
Jason Aryeh
Director
Oct 30, 2026Sale−52$320.24$16.65K110,717
Jason Aryeh
Director
Oct 30, 2026Sale−50$318.23$15.91K110,769
Jason Aryeh
Director
Oct 30, 2026Sale−50$317.74$15.89K110,819
Andrew Reardon
CLO & Secretary
Oct 2, 2026Sale(10b5-1 plan)−17$307.74$5.23K31,854
Andrew Reardon
CLO & Secretary
Oct 2, 2026Sale(10b5-1 plan)−235$307.19$72.19K31,871
Andrew Reardon
CLO & Secretary
Oct 2, 2026Sale(10b5-1 plan)−404$306.18$123.70K32,106
Andrew Reardon
CLO & Secretary
Oct 2, 2026Sale(10b5-1 plan)−1,535$304.52$467.43K32,510
Andrew Reardon
CLO & Secretary
Oct 2, 2026Sale(10b5-1 plan)−1,976$303.54$599.80K34,045
Andrew Reardon
CLO & Secretary
Oct 2, 2026Sale(10b5-1 plan)−833$302.51$251.99K36,021
Andrew Reardon
CLO & Secretary
Oct 2, 2026Option exercise+340$52.27$17.77K36,854
Martine Zimmermann
Director
Sep 22, 2026Tax withholding−115$298.50$34.33K3,782
Martine Zimmermann
Director
Sep 10, 2026Sale−1,200$285.00$342.00K3,897
Andrew Reardon
CLO & Secretary
Sep 3, 2026Sale(10b5-1 plan)−400$288.98$115.59K36,514
Andrew Reardon
CLO & Secretary
Sep 3, 2026Sale(10b5-1 plan)−300$283.99$85.20K41,214
Andrew Reardon
CLO & Secretary
Sep 3, 2026Sale(10b5-1 plan)−2,115$286.36$605.65K37,299
Andrew Reardon
CLO & Secretary
Sep 3, 2026Sale(10b5-1 plan)−1,800$285.17$513.31K39,414
Andrew Reardon
CLO & Secretary
Sep 3, 2026Sale(10b5-1 plan)−385$287.53$110.70K36,914
Jason Haas
Director
Aug 12, 2026Sale−7,138$292.81$2.09M3,981
Jason Haas
Director
Aug 12, 2026Option exercise+6,138$51.56$316.48K11,119
Octavio Espinoza
Chief Financial Officer
Aug 12, 2026Option exercise+2,869$55.75$159.95K48,818
Octavio Espinoza
Chief Financial Officer
Aug 12, 2026Option exercise+2,074$70.04$145.26K45,949
Octavio Espinoza
Chief Financial Officer
Aug 12, 2026Sale(10b5-1 plan)−31,641$292.07$9.24M27,696
Octavio Espinoza
Chief Financial Officer
Aug 12, 2026Option exercise+7,171$57.22$410.32K55,989
Octavio Espinoza
Chief Financial Officer
Aug 12, 2026Option exercise+3,348$68.74$230.14K59,337
Octavio Espinoza
Chief Financial Officer
Aug 12, 2026Option exercise+16,179$52.84$854.90K43,875
Andrew Reardon
CLO & Secretary
Aug 3, 2026Sale(10b5-1 plan)−503$289.80$145.77K43,114
Andrew Reardon
CLO & Secretary
Aug 3, 2026Sale(10b5-1 plan)−356$288.75$102.80K43,617
Andrew Reardon
CLO & Secretary
Aug 3, 2026Sale(10b5-1 plan)−1,214$287.77$349.35K43,973
Andrew Reardon
CLO & Secretary
Aug 3, 2026Sale(10b5-1 plan)−1,032$286.80$295.98K45,187
Andrew Reardon
CLO & Secretary
Aug 3, 2026Sale(10b5-1 plan)−157$285.74$44.86K46,219
Andrew Reardon
CLO & Secretary
Aug 3, 2026Sale(10b5-1 plan)−33$284.55$9.39K46,376
Andrew Reardon
CLO & Secretary
Aug 3, 2026Sale(10b5-1 plan)−105$284.14$29.83K46,409
Andrew Reardon
CLO & Secretary
Aug 3, 2026Option exercise+5,000$52.27$261.35K46,514
Andrew Reardon
CLO & Secretary
Aug 3, 2026Sale(10b5-1 plan)−409$292.82$119.76K41,514

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
2M shares short
Days to cover
10.5
At 0M shares a day
Change since last report
-1.5%
From 3M shares
Short volume, 20 days
68.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Ligand Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,586 shares on Sep 3, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Jason Aryeh
Director
Nov 10, 20263,000$960.08KNov 10, 2026Secondary Market Purchase
Jason Aryeh
Director
Nov 4, 2026282$90.23KNov 4, 2026Secondary Market Purchase
Jason Aryeh
Director
Nov 2, 2026700$221.60KNov 2, 2026Secondary Market Purchase
Jason Aryeh
Director
Oct 30, 20261,209$385.19KOct 30, 2026Restricted Stock
Jason Aryeh
Director
Oct 30, 2026202$64.74KOct 30, 2026Open Market Purchase
Martine Zimmermann
Director
Sep 10, 20261,200$342.00KSep 10, 2026Restricted Stock
Andrew Reardon
Officer
Sep 3, 202615,000$4.30MSep 3, 2026Exercise of Stock Options
Octavio Espinoza
Officer
Aug 12, 202631,641$9.14MAug 12, 2026Exercise of Stock Options
Jason Haas
Director
Aug 12, 20267,138$2.09MAug 12, 2026Stock Option Exercise
Andrew Reardon
Officer
Jul 1, 202610,000$3.16MJul 1, 2026Exercise of Stock Options
Stephen L. Sabba
Director
Jun 16, 20262,145$544.83KJun 16, 2026Stock Option Exercise
Jason Haas
Director
Jun 12, 20266,461$1.65MJun 12, 2026Stock Option Exercise
Jason Aryeh
Director
Jun 11, 20264,500$1.12MJun 11, 2026Open Market Purchase
Jason Aryeh
Director
Jun 10, 20265,000$1.25MJun 10, 2026Open Market Purchases
John L. Lamattina
Director
Jun 10, 20264,519$1.13MJun 10, 2026Restricted Stock

Congress trades

5 trades in Ligand Pharmaceuticals reported by 2 members of the House

MemberTypeTradedAmountFiled
Gilbert Cisneros
CA31
BoughtMay 29, 2026$1K–15KJun 8, 2026
Gilbert Cisneros
CA31
BoughtMar 3, 2026$1K–15KApr 7, 2026
Gilbert Cisneros
CA31
BoughtJan 15, 2026$1K–15KFeb 13, 2026
Gilbert Cisneros
CA31
BoughtJan 5, 2026$1K–15KFeb 13, 2026
Lamar Smith
TX21
BoughtDec 1, 2017$1K–15KJan 9, 2018

See a number that looks wrong?